Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy
This study aims to develop test and evaluate a Patient Decision Aid called "The Decision Helper" among melanoma patients eligible for adjuvant treatment.

Is the Decision Helper an acceptable tool for patients and clinicians and is it feasible in clinical practice?
Are there any differences in the levels of decisional regret in the patients who have not used the Decision Helper (pre-implementation) compared to the ones who have (post-implementation?
- EligibilityCriteria: Inclusion Criteria:  Danish speaking Diagnosed with stage 3 malignant melanoma Eligible for adjuvant immunotherapy  Exclusion Criteria:  Metastatic disease Mental impairment - Gender: All - MinimumAge: 18 Years - MaximumAge: 100 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Adult patients diagnosed with malignant melanoma who at about to receive adjuvant therapy with immunotherapy or targeted therapy - SamplingMethod: Non-Probability Sample